Contact us  |  Disclaimer  |  Sitemap
  • ABOUT US
  • MISSION & VALUES
  • MANAGEMENT
  • BOARD OF DIRECTORS
  • COMMITTEES
  • CORPORATE GOVERNANCE
    • GOVERNANCE DOCUMENTS
    • RISK MANAGEMENT
    • REPORTING COMPLIANCE VIOLATIONS AND CONCERNS
    • VELOXIS AS WHISTLEBLOWER POLICY
    • WHISTLEBLOWING GUIDSELINES FOR REPORTED EMPLOYEES
  • CAREERS
ABOUT US
  • CLINICAL STUDIES
CLINICAL STUDIES
  • PRODUCTS
PRODUCTS
  • MELTDOSE® TECHNOLOGY
TECHNOLOGY
  • INVESTOR RELATIONS
  • RELEASES
  • DOWNLOAD CENTER
  • CALENDAR
  • FINANCIAL INFORMATION
    • OUTLOOK
  • STOCK INFORMATION
    • HISTORIC STOCK LOOKUP
    • INVESTMENT CALCULATOR
    • ORDER DEPTH AND LATEST TRADES
    • DIVIDEND HISTORY
    • ANALYST COVERAGE
  • General Meetings
INVESTOR
  • MEDIA
MEDIA
  • INVESTOR RELATIONS
  • RELEASES
  • DOWNLOAD CENTER
  • CALENDAR
  • FINANCIAL INFORMATION
    • OUTLOOK
  • STOCK INFORMATION
    • HISTORIC STOCK LOOKUP
    • INVESTMENT CALCULATOR
    • ORDER DEPTH AND LATEST TRADES
    • DIVIDEND HISTORY
    • ANALYST COVERAGE
  • General Meetings

Dividend History


At this stage of Veloxis' development, the Company has not paid dividends and does not intend to do so.


Shareholder Briefcase

email alerts

download library

snapshot

mobile investor

RSS News Feeds

Print Page

Email Page

Share this on: Close window
delicious Delicious
Digg Digg
Facebook Facebook
LinkedIn LinkedIn
Twitter Twitter
What is this?

Veloxis Pharmaceuticals A/S | c/o Plesner Advokatpartnerselskab | Amerika Plads 37 | 2100 København Ø | Tel. +4570333300 | CVR-no. 26 52 77 67 | info@veloxis.com